PNV 2.35% $2.61 polynovo limited

The Clinicians Speak, page-1034

  1. 2,903 Posts.
    lightbulb Created with Sketch. 743
    Excellent observation.
    There are varied practices among the surgeons and it tells me there is still a large unmet opportunity that can be realized through steady support of communications from BTM advanced practitioners to other either interested or early in their understanding of it's utility.
    The company is certainly finding ways to support surgeons to spread the word.
    I wonder what additional channels might be employed to accelerate the organic uptake? I watched some Cath Lab videos that were part of a live practice summit a little while ago. I wonder if video linked surgeon conferences that leveraged video of real practice using BTM and how easy it is to use might also spark further adoption.

 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.